Welcome Guest | Register / Login

Oncology Market Research Reports

Sort By
Title Published Price
Clovis Oncology Inc (CLVS) - Financial and Strategic SWOT Analysis Review
By GlobalData
Clovis Oncology Inc (CLVS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased...
May 2019 $ 125
Global Oncology/Cancer Blockbuster Drugs Market Research Report 2019 - 2025
By DPI Research
The global 27 cancer blockbuster drugs market size is set to surpass US$ 120 billion by 2025. “Global Oncology/Cancer Blockbuster Drugs Market Research Report 2019 - 2025” presents an in-depth ...
Apr 2019 $ 1390
21st Century Oncology Inc - Strategic SWOT Analysis Review
By GlobalData
21st Century Oncology Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company's history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company's ...
Apr 2019 $ 125
US Oncology Testing Market Shares and Sales Segment Forecasts By Assay, 2019-2023
By Venture Planning Group
This report provides an overview of the US cancer diagnostics market, including market shares of leading suppliers by test, as well as volume and sales forecasts by market segment.Contains 40 pages and 7 tables...
Apr 2019 $ 850
UK Oncology Testing Market Shares and Sales Segment Forecasts By Assay, 2019-2023
By Venture Planning Group
This report provides an overview of the U.K. cancer diagnostics market, including market shares of leading suppliers by test, as well as volume and sales forecasts by market segment.Contains 16 pages and 4 tables...
Apr 2019 $ 450
Spain Oncology Testing Market Shares and Sales Segment Forecasts By Assay, 2019-2023
By Venture Planning Group
This report provides an overview of the Spanish cancer diagnostics market, including market shares of leading suppliers by test, as well as volume and sales forecasts by market segment.Contains 16 pages and 7 tables...
Apr 2019 $ 750
Japan Oncology Testing Market Shares and Sales Segment Forecasts By Assay, 2019-2023
By Venture Planning Group
This report provides an overview of the Japanese cancer diagnostics market, including market shares of leading suppliers by test, as well as volume and sales forecasts by market segment.Contains 23 pages and 6 tables...
Apr 2019 $ 750
Italy Oncology Testing Market Shares and Sales Segment Forecasts By Assay, 2019-2023
By Venture Planning Group
This report provides an overview of the Italian cancer diagnostics market, including market shares of leading suppliers by test, as well as volume and sales forecasts by market segment.Contains 18 pages and 5 tables...
Apr 2019 $ 650
Germany Oncology Testing Market Shares and Sales Segment Forecasts By Assay, 2019-2023
By Venture Planning Group
This report provides an overview of the German cancer diagnostics market, including market shares of leading suppliers by test, as well as volume and sales forecasts by market segment.Contains 25 pages and 7 tables...
Apr 2019 $ 750
France Oncology Testing Market Shares and Sales Segment Forecasts By Assay, 2019-2023
By Venture Planning Group
This report provides an overview of the French cancer diagnostics market, including market shares of leading suppliers by test, as well as volume and sales forecasts by market segment.Contains 25 pages and 7 tables...
Apr 2019 $ 750
Kura Oncology Inc (KURA) - Financial and Strategic SWOT Analysis Review
By GlobalData
Summary Kura Oncology Inc (Kura Oncology) is a clinical-stage biopharmaceutical company that discovers and develops therapeutics for the treatment of solid tumors and blood cancers. The company's lead drug candidate Tipifarnib, an inhibi...
Mar 2019 $ 300
Champions Oncology Inc (CSBR) - Financial and Strategic SWOT Analysis Review
By GlobalData
Summary Champions Oncology Inc (Champions), formerly Champions Biotechnology Inc, is a developer of advanced technology solutions and services to personalize the development and use of oncology drugs. The company's technology platform is...
Mar 2019 $ 300
ZIOPHARM Oncology Inc (ZIOP) - Financial and Strategic SWOT Analysis Review
By GlobalData
Summary Ziopharm Oncology Inc (Ziopharm), is a provider of next-generation immune therapies. The company offers Controlled IL-12 and t-cell therapy to fight blood cancers and solid tumors. Its Controlled IL-12 platform provides therapy ...
Mar 2019 $ 300
The US Oncology Network - Strategic SWOT Analysis Review
By GlobalData
The US Oncology Network - Strategic SWOT Analysis Review provides a comprehensive insight into the company's history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company's ke...
Feb 2019 $ 125
Champions Oncology Inc (CSBR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
By GlobalData
Summary Champions Oncology Inc (Champions), formerly Champions Biotechnology Inc, is a developer of advanced technology solutions and services to personalize the development and use of oncology drugs. The company's technology platform is...
Nov 2018 $ 250
Gritstone Oncology Inc (GRTS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
By GlobalData
Summary Gritstone Oncology Inc (Gritstone) develops and commercialize tumor-specific cancer immunotherapies. The company's pipeline product portfolio comprises GRANITE-001, for solid tumors, including metastatic non-small cell lung cance...
Nov 2018 $ 250
Strata Oncology Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
By GlobalData
Summary Strata Oncology Inc (Strata Oncology) is a precision oncology company. The company offers tumor sequencing to advanced cancer patients and a portfolio of biomarker-matched precision medicine trials. It identifies patients to desi...
Nov 2018 $ 250
Oncology Venture ApS - Pharmaceuticals & Healthcare - Deals and Alliances Profile
By GlobalData
Summary Oncology Venture ApS (Oncology Venture), a subsidiary of Oncology Venture Sweden AB, is a developer of oncology products. The company offers products in the therapeutic areas of metastatic breast cancer, ovarian cancer, renal can...
Nov 2018 $ 250
F1 Oncology Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
By GlobalData
Summary F1 Oncology Inc (F1 Oncology) is a developer of adoptive cellular therapy candidates. The company develops CAB technology to mitigate the on-target, off-tumor toxicity of Chimeric Antigen Receptor (CAR) T cell therapy. It is deve...
Nov 2018 $ 250
Invictus Oncology Pvt Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
By GlobalData
Summary Invictus Oncology Pvt Ltd (Invictus Oncology) is a biopharmaceutical company with focus on the discovery, development and commercialization of anti-cancer drugs. The company develops platinum-based drugs to treat various types of...
Nov 2018 $ 250
21st Century Oncology Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
By GlobalData
Summary 21st Century Oncology Inc. (21st Century Oncology), a subsidiary of 21st Century Oncology Holdings, Inc., is a provider of integrated cancer care services (ICC). It operates through an integrated network of cancer treatment cente...
Nov 2018 $ 250
Clovis Oncology Inc (CLVS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
By GlobalData
Summary Clovis Oncology Inc (Clovis) is a biopharmaceutical company that acquires, develops and commercializes new anti-cancer agents. The company's development programs are targeted at specific cancer indications, combining personalized...
Nov 2018 $ 250
European Institute of Oncology - Pharmaceuticals & Healthcare - Deals and Alliances Profile
By GlobalData
Summary European Institute of Oncology (IEO) is a research institute that conducts clinical and scientific research on cancer prevention, early diagnosis and treatment of cancer. The institute offers medical care services for breast tumo...
Nov 2018 $ 250
Sierra Oncology Inc (SRRA) - Medical Equipment - Deals and Alliances Profile
By GlobalData
Summary Sierra Oncology Inc (Sierra Oncology), formerly ProNAi Therapeutics Inc is a clinical stage drug development company that develops and commercializes DNA damage response therapeutics for the treatment of cancer. The company's pro...
Oct 2018 $ 250
Surface Oncology Inc (SURF) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
By GlobalData
Summary Surface Oncology Inc (Surface Oncology) is an immuno-oncology company that develops novel antibody therapies for the treatment of cancer. The company's lead product candidate SRF231 is a human antibody that inhibits the activity ...
Oct 2018 $ 250
We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy